'Compelling and landmark' results will ‘fundamentally change’ the journey of patients with stage 2 and 3 early breast cancer, specifically those in need of new, well-tolerated options to prevent their cancer from coming back.
The US Food and Drug Administration will soon require researchers and companies seeking approval for late-stage clinical trials to submit a diversity plan for trial participants. Scott Gray, CEO of Clincierge, discusses how trial sponsors and CROs can...
The UK has the tools to become a life-sciences superpower but those thinking about taking part remain put off by the lack of financial motivation, a clinical trials start-up says.
With an increase in clinical studies demanding an increase in CRAs, we spoke to Sara Brannon, director of quality and training development, at ICON, to find out their approach to recruiting and how the industry is suffering due to a global shortage because...
Cognizant has announced a platform that can use it consulting, advisory, ecosystem partnership along with digital studios and industry knowledge to help its clients transition to generative artificial intelligence (AI).
Helmholtz Munich, one of Germany’s 19 research centers, that develops future solutions and technologies has selected DataDirect Networks (DDN) to accelerate its artificial intelligence (AI) driven discoveries.
AARDEX Group has joined forces with other industry companies to partner with a new project from The Digital Medical Society (DiMe) called Extending the Verification, Analytical Validation, and Clinical Validation – or V3+ Framework.
Results from a multinational trial of trifluridine/tipracil, known as Lonsurf, with or without bevacizumab in refractory metastatic colorectal cancer (mCRC) have resulted in statistically significantly and clinically meaningful improvements.
Rich Christie is chief medical officer at AiCure LLC. He is a firm believer in digtal biomarkers and the audio and visual biomarkers that can be captured through a front-facing camera. OSP inteviewed him to find about more about the changing landscape...
Scorpion Therapeutics, a clinical-stage oncology company, has announced that the first patient has been dosed in a phase 1/2 clinical trial of STX-478, its treatment for breast cancer and other solid tumors.
The company announces plans to reorganize its business to focus on design-and-deployment engagements for on-site implementation of automated cloud labs.
Unifying medicinal development processes and data within a connected technology ecosystem will enhance collaboration, two partnering companies using a development cloud have said.
In its bid to what it says will make participation in clinical trials easier and more sustainable, Greenphire has revealed a patient-powered registry and it has also expanded a deal with Merck.
In the second and final part of an interview with Medable’s chief growth officer and women’s health champion, Sanskriti Thakur, discover her views on vital changes that need to be made. She discusses ways to ensure the importance of women’s roles in clinical...
Charité – Universitätsmedizin Berlin, one of Europe’s largest university hospitals is collaborating with UK-based Exscientia to make use of an artificial intelligence-driven precision medicine platform in haematological cancers.
When the pandemic broke, the whole world was thrown onto a steep learning curve. Everyone had to find new ways to adapt in their day to day lives as well as their working lives. There was no exception with clinical trials, with patients unable to attend...
Our world is getting greener – or at least trying to with more people turning to electric vehicles, buying local seasonal fruit and vegetables, cafes and restaurants adopting paper straws and a growth in sales of eco-friendly home products, to name a...
In the first of a two-part interview with Medable’s chief growth officer, Sanskriti Thakur, we will learn about why she thinks the world of medicine is letting women down, what the future holds and how everyone should be paying more attention.
Father and software engineer, Vincent Keunen combined his personal experience of leukemia and his son's bone cancer with his professional skills to provide all patients with a tool to manage their health information on their smartphone.
The partners announce that they will combine to use artificial intelligence to improve the identification and enrolment of patients for clinical trials.
The company published a report finding that almost a fifth of trial sites only recruit one patient, Phesi’s CEO explained to Outsourcing-Pharma what the reaction at the event had been.
The two companies will come together to provide a ‘patient-centered solution’ for clinical research, combing uMotif’s patient engagement platform with ActiGraph’s wearable technology.
Steve Rosenberg has been a life science and healthcare executive for 40+ years and is currently CEO of uMotif. He commercialized the first integrated clinical technology suite at Phase Forward/Oracle. Top pharma and biotech executives depend on him for...
Hataali has introduced a new version of its blockchain-based advanced therapy platform to address one of the key supply chain challenges faced by contract manufacturers and pharma companies today.
A partnership to put an end to the ‘tremendously manual and time-consuming’ collection of clinical data and medication history has been formed between health information (HIN) Health Gorilla and DrFirst, a healthcare technology solutions consultancy.
The cryptocurrency space suffered through a torrid, scandal-marked 2022 but there remains interest in using the blockchain infrastructure that underpins the sector in other contexts. In a recent review of the potential of the blockchain in healthcare,...
Digital twins could overcome common data management issues at equipment-intense research facilities, according to a paper published in the journal Sensors.
A fleet of legal professionals offers advice and perspective on important considerations when harnessing artificial intelligence and real-world evidence.
Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines.
The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.
The AI and QC specialists have joined to use AI and QC in order to discover biological pathways relevant to the treatment of triple-negative breast cancer.
Signant Health has partnered with the software company o connect its platforms for the management of clinical supply chain inventory, labels, and content.